AI assistant
Sending…
SynAct Pharma — Major Shareholding Notification 2023
Nov 3, 2023
3114_iss_2023-11-03_1d23c9ad-0d16-4932-96c6-9ecd037cec77.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer SynAct Pharma AB
Holder
Thomas Jonassen
Instrument
| Instrument | Ordinary SE0008241491 | ||
|---|---|---|---|
| Before the transaction | |||
| Shares | 3,531,644 | ||
| Voting rights | 3,531,644 | ||
| Transaction | |||
| Reason for major shareholding notification Invalidated | |||
| Date | 01/11/2023 | ||
| Limit for number of shares | 10 % | ||
| Limit for number of votes | 10 % | ||
| After the transaction | |||
| Quantity | |||
| Shares | 2,489,644 | ||
| Directly held voting rights | 0 | ||
| Indirectly held voting rights | 2,489,644 | ||
| Percentage | |||
| Directly held shares | 6.99909 % | ||
| Directly held voting rights | 0 % | ||
| Indirectly held voting rights | 6.99909 % | ||
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 6.99909 % | 2,489,644 | |
| paragraph, line 2 | Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
Instruments - FITA Ch. 4, section 2, first | |
| - Physically settled - Cash settled |
|||
| Total | 6.99909 % | 2,489,644 | |
| Chain of controlling companies Voting rights % Voting rights Company |
|||
| 6.04792 | 6.04792 | Bioinvest ApS | |
| 0.87005 | 0.87005 | Goodwind Holding GmbH | |
| 0.08112 | 0.08112 | TJ Biotech Holding ApS | |
| Group total holdings | |||
| Voting rights | 2,489,644 | ||
| Percentage of voting rights 6.99909 | |||
| Notes (other relevant informations according to law) | |||
| Makulerad per förfrågan från anmälare | |||
| Published |
03/11/2023 16:47
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from SynAct Pharma
Regulatory Filings
2026
May 8
AGM Information
2026
May 7
Board/Management Information
2026
Apr 23
Governance Information
2026
Apr 23
Annual Report
2026
Apr 15
Major Shareholding Notification
2026
Apr 7
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 2